Previous studies have associated mu-opioid receptor (OPRM1) genotype with pain and analgesia responses in postoperative and patient populations. This study investigates the role of catechol-O-methyltransferase (COMT) and OPRM1 genotypes in acute postoperative pain scores, opioid use, and opioid-induced sedation after surgical procedures for orthopedic trauma in an otherwise healthy patient population. Verbal pain/sedation scores, opioid use, and physiologic responses in the immediate postoperative period were examined for association with genetic variants in Caucasians genotyped for OPRM1 single nucleotide polymorphisms (SNPs) A118G and C17T and COMT SNPs. The OPRM1 A118G genotype was associated with patients' postoperative Numerical Pain scale (NPS) ratings at 15 min in the postanesthesia care unit (PACU) (p ¼ .01) and patients' sedation scores at 15 min in the PACU (p ¼ .02). COMT genotype (rs4818) was associated with opioid consumption in the first 45 min in the PACU (p ¼ .04). NPS ratings at 45 min were also higher in the group of patients with A/A genotype of rs4680 than in patients with the other two genotypes at this SNP (p ¼ .03). Our haplotype trend analysis identified a COMT haplotype ''GCGG'' significantly associated with NPS at 15 min (p ¼ .0013), amount of opioids consumed in the first 45 min (p ¼ .0024), and heart rate at 45 min in the PACU (p ¼ .017). The results indicate that genetic variations in COMT contribute to the acute postoperative pain and analgesia responses and physiologic responses in this group of otherwise healthy postoperative orthopedic trauma patients.
Factors associated with variability in responses to opioids include age (Likar et al., 2008) , gender (Cepeda & Carr, 2003) , and previous opioid use (Fillingim et al., 2005; Patanwala, Jarzyna, Miller, & Erstad, 2008; Paulson, Minoshima, Morrow, & Casey, 1998) . Researchers have also suggested genetic variants as an additional factor contributing to individual variability in responses to opioids Chou, Yang, et al., 2006; Reyes-Gibb et al., 2007) . Variability in genotypes for the mu-opioid receptor gene (OPRM1) on chromosome 6q 24-25 has been evaluated to determine whether single nucleotide polymorphisms (SNPs) account for individual differences in postoperative pain. Investigators have found patients undergoing abdominal hysterectomy , Cesarean section, (Sia et al., 2008) , or total knee arthroplasty (Chou, Yang, et al., 2006) to have differences in opioid use and pain scores associated with genotype for the A118G SNP of OPRM1. Other SNPs located in OPRM1 such as C17T, T1793A, A1320G, and C11T have been associated with substance dependence (Lotsch, Skarke, Liefhold, & Geisslinger, 2004) but have not been evaluated in postoperative patients for association with opioid requirements.
Genetic variants of the gene for catechol-O-methyltransferase (COMT) on chromosome 22q11.2 have also been identified as contributing to the variability in pain and responses to opioids. Kim, Lee, Rowan, Brahim, and Dionne (2006) found an association between a COMT SNP rs740603 and maximum postoperative pain rating. In addition, the COMT Val158Met polymorphism (rs4680) has been associated with greater opioid requirements in cancer patients (Rakvag et al., 2008; Reyes-Gibb et al., 2007) . Haplotype analysis of COMT SNPs, rs5746849, rs740603, rs6269, rs2239393, and rs4818 has shown that in the Caucasian population, carriers of the most frequent haplotype needed less morphine than noncarriers; however, investigators found no significant differences in patient symptoms such as pain, fatigue, and nausea between carriers and noncarriers (Rakvag et al., 2008) .
One of the concerns when giving opioids, particularly to the opioid-naive patient, is opioid-induced sedation (OIS). Lentschener and colleagues (Lentschener, Tostivint, White, Gentili, & Ozier, 2007) found a high incidence of OIS in postoperative patients. OIS is a considerable concern because it is a precursor to opioid-induced respiratory depression. Further, few risk factors for OIS have been identified (Pattinson, 2008) . In recent studies, Chou and colleagues Chou, Yang, et al., 2006) did not find an association between the OPRM1 A118G SNP and sedation scores.
Patients under the effects of anesthesia cannot provide an indication of pain to anesthesia providers. Instead, providers assess pain by evaluating the autonomic nervous system responses of heart rate and respiratory rate during surgery. Identification of genotypes that help predict postoperative pain and OIS prior to surgical intervention would improve and increase the safety of treatment of postoperative pain. The purpose of this pilot study was to explore the relationships of OPRM1 and COMT genotypes with postoperative pain reports, opioid use, and OIS in the immediate postoperative period in patients after surgical procedures for orthopedic trauma.
Method Subjects
After obtaining approval from the institutional review board and written informed consent from participants, we prospectively enrolled 79 Caucasian adult subjects having surgery for isolated orthopedic trauma of the upper or lower extremities. We collected patients' demographic data including gender, race, ethnicity, age, weight, smoking, anatomic site of repair, and length of surgical, operating room and postanesthesia care unit (PACU) time. We excluded subjects for multiple fracture sites, other traumatic injuries (e.g., head, thoracic, abdominal), opioid use 6 months prior to injury, depression, neuropathy, liver disease, kidney disease, recreational drug use in the last 6 months, or a history of alcohol abuse (consistently greater than three drinks/day).
Anesthesia Management
Participants received either general anesthesia alone (n ¼ 66) or general anesthesia with regional anesthesia (n ¼ 13). Regional techniques included sciatic (n ¼ 9), lumbar plexus (n ¼ 2), combination sciatic, femoral and popliteal fossa blocks (n ¼ 1), and one unknown. Participants received 2-4 mg midazolam prior to anesthesia induction. For induction, patients usually received propofol, although some received sodium thiopental. Muscle relaxants used during induction included succinylcholine and/or rocuronium. Inhaled anesthetic agents used during the maintenance phase included isoflurane, sevoflurane, or desflurane.
Pain Assessment
We assessed pain using an 11-point verbal response Numeric Pain scale (NPS) with ratings from 0 (no pain) to 10 (pain as bad as I can imagine). We taught participants how to use the scale prior to surgery and asked them to verbally report a pain score in the preoperative holding area and then within the first 15 min and at 45 min after arrival in the PACU. Data collectors completed interrater verification of scoring on the first 3-5 patients.
Opioid Use
Opioids administered during the first 45 min after admission to the PACU included fentanyl, hydromorphone, morphine, and meperidine. We recorded time and amount of opioids administered during this period from the PACU record. If the participant received opioids via patient-controlled analgesia, study personnel recorded the amount the patient received in the first 45 min in the PACU. We converted the amount of opioid administered to morphine equivalents, as follows: 100 mg fentanyl, 1.5 mg hydromorphone, or 75 mg of meperidine were converted to 10 mg of morphine (Berry, Covington, Dahl, Katz, & Miskowski, 2006) . We report the amount of opioids received by patients as the absolute amount of opioid and the amount of opioid per kg of body weight.
OIS Measurement
We collected sedation scores at 15 and 45 min after participants entered the PACU using the University of Pittsburgh Medical Center (UPMC)-Presby Sedation scale. In this scale, 0 ¼ none (alert), 1 ¼ mild (occasionally drowsy, easy to arouse), 2 ¼ moderate (frequently drowsy; easy to arouse), 3 ¼ severe (somnolent; difficult to arouse), S ¼ sleep (normal sleep, easy to arouse), U ¼ unable to assess. We were missing sedation scores for 19 participants and thus excluded them from the genetic association analysis.
Heart and Respiratory Rates
We collected heart rate (beats/min) and respiratory rate (breaths/min) at 15 and 45 min after patients' admission to the PACU. For heart rate, we used the electrocardiogram (ECG) rate on a Phillips monitor (model MP50, Andover, MD); for respiratory rate, we used ECG electrode plethysmography. In practice, anesthesia providers use heart rate, blood pressure, and tachypnea as indicators of patient pain.
Genotyping
We collected saliva samples during participants' hospital stay using the Oragene deoxyribonucleic acid (DNA) selfcollection kit from DNA Genotek Incorporated (Ottawa, Ontario, Canada). This collection kit contains a vial for saliva collection where, upon closing of the vial, the saliva mixes with a stabilization buffer. We extracted DNA from the saliva/buffer combination utilizing the protocol and reagents for extraction supplied with the Oragene kit.
We genotyped three polymorphisms within OPRM1, including A118G (rs1799971), G24A (rs1799973), and C17T (rs1799972), but we report results for only two of these due to lack of variability for G24A in our sample. Because genotyping these polymorphisms is not amenable to certain genotype collection methodologies due to their close proximity to one another, we decided to genotype them using sequencing. This decision was facilitated by the fact that both variants are within 101 bp in exon 1 and therefore could be evaluated using one sequencing reaction. We used the forward primer (5 0 -TCAGTACCATGGACAGCAG-3 0 ) and reverse primer (5 0 -GGAGTAGAGGGCCATGAT-3 0 ) in a polymerase chain reaction (PCR) with an annealing temperature of 59 C. We cleaned the PCR products using exoSAP reagents (USBiochemicals, Cleveland, OH) and sequenced them using the reverse primer and Big Dye Cycle Sequencing reagents (Applied Biosystems, ABI, Foster City, CA). We electrophoresed the sequencing products using an ABI377 automated sequencer (ABI) and viewed the data and assigned genotypes using Sequencer software (Gene Codes Corporation, Ann Arbor, MI).
We chose four SNPs-rs6269, rs4633, rs4818, and rs4680-to evaluate COMT based on previously identified haplotypes (Diatchenko et al., 2005) . Previous investigators have proposed that COMT genotypes affect opioid responses due to opioid effects on production of catecholamines in dopaminergic neurons in the brain (Furst, 1990; Zubieta et al., 1996) . We genotyped all COMT SNPs using 5 0 exonuclease Assay-on-Demand TaqMan assays (ABI). We conducted amplification and genotype assignments using the ABI7000 and SDS 2.0 software (ABI). For all genotyping conducted for this research, we made double-masked genotyping assignments for each variant, compared them, and addressed each discrepancy using raw data or by regenotyping.
Statistical Analysis
We treated pain scores, heart rate, respiratory rate, sedation scores, and opioid use in the immediate postoperative period as dependent variables and assessed them for normality using the Shapiro-Wilk test. We transformed variables that deviated from this assumption into normal scores for association analysis.
We assessed Hardy-Weinberg equilibrium (HWE; i.e., both allele and genotype frequencies in a population remain constant) for all genotypes in all available samples using the exact test implemented in PLINK (Purcell et al., 2007; Wigginton, Cutler, & Abecasis, 2005) . We used the Haploview software (http://www.broad.mit.edu/mpg/haploview) to compute the pairwise linkage disequilibrium (LD) between the selected four COMT SNPs measured by Lewontin's D 0 (e.g., D/D max , proportion of observed LD out of maximum possible LD) and to show the LD block graphically (Barrett, Fry, Maller, & Daly, 2005) . In a visually appealing and interactive interface, Haploview provides researchers a one-stop solution for common marker quality statistics, LD information, haplotype blocks (segments of strong LD within which there is little evidence for ancestral recombination events), and single marker association statistics in a user-friendly format.
We used multiple linear regression analysis to evaluate the association of each SNP with a dependent variable under additive, dominant, and recessive genetic models. In addition to each single SNP, we investigated effects of several covariates including age, gender, anesthesia plan (general vs. general with regional block), type of fracture, and smoking on the dependent variables using stepwise selection procedure, with a significance level (or p value) of .05 needed to keep a covariate in the final regression model.
We constructed COMT haplotypes using the SAS/Genetics module (SAS version 9.2; Cary, NC), which implements a Bayesian method that is fairly robust against deviations from HWE for genotypes. We first combined all haplotypes with less than 1% of haplotype frequency into a rare haplotype category (unique haplotype ! 1% itself treated as a single category). We performed a haplotype trend regression (HTR) analysis (Zaykin et al., 2002) in which we treated each haplotype category as an independent predictor to model the effect of haplotypes on our traits of interest under additive, dominant, and recessive models after adjustment for covariates using the same stepwise selection procedure as for single SNP analysis.
Because this was intended as a pilot genetic association study, we restricted analyses to Caucasian patients that underwent surgical procedures for orthopedic trauma and applied no formal correction for multiple testing. Nevertheless, we discuss the potential effects of multiple testing adjustments accordingly when we interpret and generalize our association results.
Results
Demographic and clinical characteristics of all study subjects are shown in Table 1 . The sample consisted of 79 Caucasian subjects, 18-70 years of age, with mostly lower extremity fractures (ankle/tibia/fibula). Minor allele frequency (MAF), p value of the HWE test, and total number of three different genotypes for every SNP are reported in Table 2 . For the A118G (rs1799971) SNP in OPRM1, the MAF of allele G was 0.14. We combined the two individuals in the GG group with the GA group (n ¼15) and compared them with the AA group (n ¼ 51) in association analyses. For C17T (rs1799972), there was no individual with the homozygous genotype TT (MAF of T is 0.007), we observed only one individual with the genotype TC, and another 67 individuals had homozygous genotype CC. Therefore, we performed no comparison among the three genotype groups for this SNP. We found that two COMT SNPs, rs4633 and rs4680, deviated from HWE with p values of .004 and .03, respectively. After performing a systematic lab review of raw genotype data, we were not able to identify problematic genotyping issues that would have caused the SNPs to be out of HWE.
Single Marker Analysis
We plotted the distribution of different measurements including NPS scores, sedation scores, and opioid consumption for each genotype of OPRM1 A118G rs1799971 and COMT rs6269, rs4633, rs4818, and rs4680 in Figure 1 . Assuming a dominant genetic model of minor allele G (equivalent to a two-sample comparison of group means between the AAþAB group and the BB group in Figure 1 ), we found OPRM1 rs1799971 to be modestly associated with patients' postoperative NPS pain ratings at 15 min after arrival in the PACU (p ¼ .01), after adjustment for significant (p < .05) covariates age, anesthesia plan, and weight. Assuming the same dominant model, rs1799971 was also modestly associated with patients' sedation scores at 45 min after arrival in the PACU (p ¼ .02), after adjustment for covariate anesthesia plan. These findings were consistent with data showing that the common homozygous genotype group (BB in Figure 1 ) appeared to have higher NPS scores at 15 min and lower sedation scores at 45 min than the two other genotype groups that contain the rare allele.
As shown in Figure 1 , the COMT SNP rs4818 was modestly associated with the amount of opioids patients consumed in the PACU during the first 45 min (p ¼ .04), after adjustment for significant covariates anesthesia plan and weight, assuming a recessive model for allele G. Patients who were G/G homozygotes for rs4818 consumed less opioids than patients in the other two genotypic groups. The patients' postoperative NPS scores at 15 and 45 min in the rare A/A genotype group of the nonsynonymous rs4680 (Val158Met) were higher than those in the heterozygous A/G group and homozygous G/G group (p ¼ .05 and .03, respectively).
Haplotype Analysis
Pairwise analysis by the Haploview software showed that three COMT SNPs, rs6269, rs4633, and rs4818, are in strong LD (D 0 > 0.80) and they are in low LD with rs4680 ( Figure 2) . Although physical distance is a major factor for LD estimation, other factors also affect LD, such as sample size, allele frequency, type of polymorphism, and genomic location of markers (Zaykin et al., 2002) , which might explain why four COMT SNPs, spanning only 1,319 bp in physical distance, are not in a single LD block in the current study ( Figure 2) . One thing to note is that the Haploview software uses a twomarker expectation-maximization to estimate the maximum likelihood values of the four gamete frequencies to calculate D 0 . Since two of the four SNPs are not in HWE, the values of LD and structure of LD patterns shown in Figure 2 might not be accurate representations. That is why we later used a Bayesian method (implemented in SAS/Genetics) that is robust to HWE departure to construct the haplotypes for HTR analysis. In view of their close physical distance and as an attempt to replicate previous studies, we still inferred the haplotypes using all four SNPs together. We identified seven haplotypes with a frequency of greater than 2%, which represented 94.2% of all haplotypes we observed in this study (Figure 2 ). Our HTR analysis identified a common haplotype ''GCGG'' (frequency ¼ 12.1%) that was significantly associated with patients' postoperative pain scores at 15 min (p ¼ .0013), the amount of opioids patients consumed in the PACU for the first 45 min (p ¼ .0024), and patients' postoperative heart rate for the first 45 min (p ¼ .017). Carrying one unit of this ''GCGG'' haplotype was associated with an increase in NPS score of 1.73, an increase in opioid consumption of 2.01 mg, and an increase in heart rate of 1.46 beats/min relative to the mean change for noncarriers in the entire study population.
Discussion
Published genetic studies of COMT and OPRM1 focus on their possible associations with pain phenotypes (Diatchenko et al., 2006; Reyes-Gibb et al., 2007) . No previous study has investigated the association between genetic variants of COMT and OIS in postoperative patients, and published studies of OPRM1 have failed to detect associations between OIS and OPRM1 polymorphisms Chou, Yang, et al., 2006; Sia et al., 2008) . One novel finding of the present study is that genetic variability of OPRM1 SNP A118G (rs1799971) is associated with individual differences in OIS in the immediate postoperative recovery period (i.e., in the PACU). Patients carrying AG and GG genotypes for rs1799971 showed lower sedation scores 15 min after admission to the PACU than patients with AA genotype, albeit significantly only prior to correction. This suggests that the minor G allele of rs1799971 may contribute to a decrease in sedation score in carriers and thus merits further investigation in larger and additional postoperative patient populations. Investigators have shown that variability in the amount of postoperative opioid (e.g., intrathecal or patient controlled analgesia morphine within 24 hr) used in patients having undergone knee arthroplasty, abdominal hysterectomy, or Caesarean section is associated with OPRM1 A118G genotypes with GG genotype carriers generally consuming more opioid than GG noncarriers Chou, Yang, et al., 2006; Sia et al., 2008) . We did not detect an association between opioid consumption and A118G; however, we only considered opioid consumption up to 45 min after arrival in the PACU, while other studies have measured opioid consumption over 24 and 48 hr. For example, Chou, Wang, and colleagues (2006) showed that GG carriers consumed more morphine at 24 hr than noncarriers, but they did not identify a statistically significant difference for morphine consumption at 48 hr. Therefore, our finding in the current study does not rule out the possibility of an association between A118G and opioid consumption if our measurement period were extended to 24 or 48 hr. Another critical difference between the current study and these previous studies is the higher frequency of the GG genotype for A118G in Asian populations Chou, Yang, et al., 2006; Sia et al., 2008) compared to the Caucasian population we investigated. Our study had only one subject with the GG genotype for A118G compared to 11% and 23% of subjects in two separate studies by Chou and colleagues Chou, Yang, et al., 2006) . Researchers have reported similar differences in genotype frequency by ancestry in studies related to substance abuse (Tan, Tan, Karupathivan, & Yap, 2003) .
The C17T SNP rs1799972 has been associated with substance abuse but to our knowledge has not been evaluated in postoperative patients. Variants for C17T are more frequently found in Blacks or African Americans and are less frequently identified in Caucasians (Bond et al., 1998) . We were not able to explore associations with this SNP in the current study of only Caucasians because no individual had the TT genotype and only one individual had the TC genotype. These findings further support the proposal that variants of C17T are infrequent in Caucasians.
Researchers have reported on the relationship of COMT genotypes with opioid use and variability in pain in an acute pain study, an experimental pain study in humans and cancer patients (Rakvag et al., 2008; Reyes-Gibb et al., 2007) . In studies that evaluated COMT and pain in cancer patients, opioid requirements differed significantly by rs4680 genotype. In addition, Rakvag and colleagues (2008) found that rs4818 genotype was associated with variability in amounts of opioid use in Caucasian cancer patients, with GG genotype carriers consuming more opioids. However, in the current study, we report the opposite trend, as our GG homozygous postoperative patients consumed less opioids than patients in the other two genotype groups. Lotta et al. (1995) found that the individuals with the val (G)/val (G) genotype of rs4680 (Val158Met) tend to have the highest COMT enzyme activity (and lowest pain sensitivity), those with the met (A)/met (A) genotype have the lowest enzyme activity (and therefore the highest pain sensitivity), and heterozygous G/A individuals are intermediate. Our findings support those findings, as that patients in the A/A genotype group of rs4680 had the highest pain scores compared to those patients in the heterozygous A/G and homozygous G/G groups. We identified a common COMT haplotype ''GCGG'' with a frequency of 12.1% and found that individuals carrying it had higher pain scores, higher opioid consumptions, and higher heart rates than those not carrying it. This finding is in contrast to Diatchenko et al.'s (2005) report in which they designated ''GCGG'' (but with a higher frequency of 36.5%) to be the haplotype associated with ''low pain sensitivity.'' This inconsistency, however, is not without explanation. First, unlike the all-female and mixed-race population Diatchenko et al.' s study of experimental pain sensitivity, in the current study, we used Caucasians of both sexes. Second, there may be a critical difference between mechanisms of experimental pain and those of acute postoperative pain experienced after repair of orthopedic trauma. Indeed, in a previous study, Kim et al. (2006) also failed to associate the ''GCGG'' haplotype with low pain sensitivity in patients following molar extraction. A recent finding from Tsao, Shabalina, Gauthier, Dokholyan, and Diatchenko (2011) may assist in clarifying these inconsistent findings: They suggest that the reduced enzyme activity of COMT driven by the genetic variability of this gene may be compensated for by increased messenger RNA translational efficiency.
There are some weaknesses that limit interpretation of results from this small pilot study. First, two of COMT SNPs were not in HWE, which might suggest genotyping errors or population admixture. However, as mentioned above, we could identify no problematic genotyping issues in our systematic lab review of raw genotype data. We used Caucasian patients in our study to alleviate the potential effects of population admixture, but the use of self-reported ancestry does not negate the possibility of an admixture effect. Furthermore, it should be noted that, although tests for HWE have been used to detect genotyping error and population admixture, those tests have relatively low power unless the sample size is large (Attia et al., 2010; Deng, Chen, & Recker, 2001) . It is worth noting that deviation from HWE or Hardy-Weinberg disequilibrium (HWD) sometimes can actually indicate a valid gene-phenotype association in fine-scale mapping of mutations responsible for diseases like alcohol and drug dependence and hereditary hemochromatosis (Feder et al., 1996; Jiang, Dong, Wang, & Sun, 2001; Lee, 2003) . Therefore, it is highly possible that the uniqueness of our patient population (or cases in other finemapping studies; Feder et al., 1996; Jiang et al., 2001) resulted in the HWD of these two COMT SNPs. In addition, our population may not represent the general population, as patients that are involved in trauma often engage in risky behaviors, for example, in athletics (Bovard, 2008) or while driving (Schermer et al., 2008) . Schermer and colleagues identified nonalcohol-related behaviors that are associated with traumatic injury such as tailgating, lack of seatbelt use, and absence of the use of a helmet when riding a motorcycle. Participation in high school and college sports has also been associated with risky behaviors that can lead to traumatic injury (Bovard, 2008) .
Second, another major weakness results from the practical decision to include a number of different surgeries and anesthesia drugs and administration techniques in this small pilot study. We tried to compensate for this problem by rigorously adjusting for effects of important clinical covariates on our dependent variables in the regression analyses. We acknowledge, however, that a larger and more homogenous sample would allow for more detailed genotype-specific analyses and the requisite test of replicability of the current findings. Third, our study was limited to Caucasians, which might prevent generalization of our findings to other race populations. Fourth, the fact that duration of patient follow-up was only 45 min limited our ability to investigate the effects of genetic markers on variability of OIS measures in postoperative patients beyond that interval. Finally, several of our findings become nonsignificant after adjusting for multiple tests. However, the Figure 2 . Graphical representation of candidate single nucleotide polymerphisms (SNPs) and linkage disequilibrium (LD) structure of catechol-O-methyltransferase (COMT) gene. The numbers inside the squares are 100 Â D 0 . |D 0 | varies between 0 (no disequilibrium) and 1 (maximum disequilibrium), represented by shades of white to dark gray. Color scheme: dark gray ¼ strong evidence of LD; light gray ¼ uninformative; white ¼ strong evidence of recombination or weak LD. ''xxxx'' indicates that no explicit alleles are depicted, as the rare haplotype is pooled from several haplotypes with a frequency below 1%. Significantly associated haplotype ''GCGG'' is highlighted with bold and italics. associations between ''GCGG'' haplotype and patients' pain scores (p ¼ .0013) and opioid consumption (p ¼ .0024) remained significant and represent a significant contribution to the understanding of heritable predisposition to postoperative pain and analgesia responses.
Significance and Nursing Practice
Opioids continue to be the primary treatment for pain in postoperative patients despite a wide range of responses among patients and multiple and even serious side effects of OIS and opioid-induced respiratory depression. While the current results generally agree with previous studies of associations between OPRM1 polymorphisms and pain and analgesia, they also indicate that association with opioid-induced side effects merit further investigation in postoperative patient populations. Although our results of associations of COMT genotype with postoperative pain, analgesia requirements and physiological responses require validation in additional populations, they suggest that this gene plays a role in the immediate postoperative period and that different relationships of pain and analgesia with specific genotypes may exist across different types of patient or subject cohorts. Such information is critical for the development of individualized treatment strategies and risk assessments.
